I agree! The science is everything. I’m in deep on HMNY and ZGNX. Waiting to sell to get in at a good entry point here again to add.
I’ve basically took a sit-back-and-see approach. This meeting with the FDA has me mildly concerned but if the science and reporting is accurate, shouldn’t be an issue.
Saltz and others- any guidance on a good entry point? I know a few cents doesn’t matter but I’m more thinking before meeting or just after? Do you think we will get clues prior?